Trial intelligence / Profile preview

18F-FAPI vs 18F-FDG PET/CT in Pancreatic Adenocarcinoma

NCT05884463Completed

Sponsor
Zhejiang University
Start
Apr 2021
Primary completion
Feb 2023
Countries
1
01

Overview

Open-label, single-arm trial, sponsored by Zhejiang University. Primary endpoints: Diagnostic value at 1 day and Maximum standardized uptake value at 1 day. Started Apr 2021; status: completed.

Beyond the preview

Go deeper on NCT05884463.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05884463.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call